MentalHealthDaily

Abnormal Brain EEG Activity Doesn’t Predict Antidepressant Efficacy in Depression (2023 Study)

by GLOOM

Depression is a multifaceted mental health condition that presents significant challenges in both diagnosis and treatment. Recent studies have explored the potential of electroencephalography (EEG) as a predictive tool for treatment outcomes in major depressive disorder (MDD), with particular focus on the response to antidepressants like escitalopram. Highlights: EEG Abnormalities & Antidepressant Response: Contrary to …

Natural Plant Polysaccharides for Depression: Antidepressant Mechanisms & Effects (2024 Review)

by GLOOM

Depression is a complex mental health disorder that affects millions of people worldwide, presenting a significant challenge for current medical treatments due to various side effects and drug resistances associated with conventional antidepressants. In response, researchers have turned their attention to natural plant polysaccharides, which have shown promising antidepressant effects through diverse mechanisms. This exploration …

Sex-Specific Biomarkers in Antidepressant Treatment for Depression: Male vs. Female (2023 Review)

by GLOOM

Depression, a complex and multifaceted disorder, presents differently in men and women, not only in symptoms but also in how each sex/gender responds to treatment. This divergence has led scientists to explore the molecular mechanisms behind these differences, revealing intricate biological and neurochemical pathways. Highlights: Sex-Specific Prevalence and Symptoms: Women are twice as likely as …

Antidepressants & Iron Pathways: Targeting Ferroptosis to Treat Depression (2023 Review)

by GLOOM

Depression, a debilitating mental disorder, stands as a significant challenge to global health, potentially becoming the leading cause of disability worldwide. Recent research has unearthed a promising connection between ferroptosis, a newly discovered form of cell death, and the onset of depression, offering fresh avenues for developing innovative antidepressant therapies. Traditional Chinese Medicine (TCM) and …

SSRI-Induced Sexual Dysfunction Reversed with “Drug Holidays” on Weekends (2024 Study)

by GLOOM

Selective serotonin reuptake inhibitors (SSRIs) are a mainstay in the treatment of various mental disorders but often come with the unwelcome side effect of sexual dysfunction. This issue can significantly affect patients’ adherence to their medication regime, often leading to treatment discontinuation. A recent clinical trial offers a new perspective, suggesting that ‘drug holidays’ – …

Pharmacogenomics (PGx) for Depression: Genetic Analysis to Amplify Antidepressant Efficacy? (2023 Review)

by GLOOM

Depression, a leading cause of disability globally, often presents challenges in treatment due to the variability in individual responses to antidepressants. Pharmacogenomic (PGx) testing, an approach aligning treatment with genetic makeup, promises to tailor depression therapy more effectively. Highlights: Major Depressive Disorder (MDD) impacts a significant portion of the global population, with traditional treatments often …

Antidepressants & Dementia Risk in Elderly Users: SSRIs vs. TCAs (2024 Study)

by GLOOM

Recent research has uncovered connections between the use of antidepressants and the risk of developing dementia in the elderly. This complex relationship, marked by varying results and considerations, is becoming a critical area of study in geriatric medicine and mental health. In light of these findings, it is crucial to delve into the nuances of …